Patriot Financial Group Insurance Agency, LLC Lineage Cell Therapeutics, Inc. Transaction History

Patriot Financial Group Insurance Agency, LLC

  • $720 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022
SELL
$1.21 - $2.48 $29,040 - $59,520
-24,000 Closed
0 $0
Q4 2021

Jan 10, 2022
SELL
$1.84 - $2.68 $25,760 - $37,520
-14,000 Reduced 36.84%
24,000 $59,000
Q2 2021

Jul 30, 2021
BUY
$2.17 - $3.0 $67,270 - $93,000
31,000 Added 442.86%
38,000 $108,000
Q4 2020

Jan 15, 2021
BUY
$0.95 - $1.83 $6,650 - $12,810
7,000 New
7,000 $12,000

Others Institutions Holding LCTX

# of Institutions
121
Shares Held
94.2M
Call Options Held
63.8K
Put Options Held
1K
View Full List

About Lineage Cell Therapeutics, Inc.

LCTX Quotes by TradingView
  • Ticker LCTX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 169,755,008
  • Market Cap $96.8M
  • Description
  • Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...
More about LCTX
Track This Portfolio

Track Patriot Financial Group Insurance Agency, LLC Portfolio

Follow Patriot Financial Group Insurance Agency, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email